New Study Holds Hope for Avoiding Serious Side Effects of Cancer Treatment
LOS ANGELES – While targeted cancer treatments have reduced side effects and improved efficacy, chemotherapy remains the backbone of combination therapies for many forms of cancer. Unfortunately, cancer patients may suffer from several side effects from chemotherapy, including infertility and a weakened defense system that makes them susceptible to life-threatening infections.
Harbor-UCLA Medical Center and the Los Angeles Biomedical Research Institute (LA BioMed) announced today that they will open a Pulmonary and Cardiac Rehabilitation Program for patients in the South Bay of Los Angeles in the first quarter of 2016. The program will be located in the National Institutes of Health-funded Chronic Disease Clinical Research Center on the LA BioMed campus. Funding for this new program comes from Harbor-UCLA Medical Center (operated by Los Angeles County) and the Pulmonary Education and Research Foundation (PERF).
LOS ANGELES – With acute appendicitis ranking among the nation’s most common acute surgical emergencies, researchers studied the relatively routine use of post-operative antibiotics in complicated cases and found that they didn’t reduce infections after surgery. They also found that patients who received post-operative antibiotics remained in the hospital up to one day longer than similar patients who had not received antibiotics.
LOS ANGELES – The National Institute of Neurological Disorders and Stroke recently awarded a grant to Phoenix Nest Inc. to partner with the Los Angeles Biomedical Research Institute (LA BioMed) to investigate the development of a therapy for treating a devastating inherited disorder, Sanfilippo disease.
LOS ANGELES — (Oct. 8, 2015)– Los Angeles Biomedical Research Institute (LA BioMed) recently received a $10,000 grant from Kaiser Foundation Hospitals, South Bay to support the Catalina Island Clinic managed by the Women’s Health Care Clinic Outreach & Education Program.
The Catalina Island Clinic provides preventive and reproductive healthcare and family planning services for uninsured, low-income women, men and teens living on Catalina Island.
LOS ANGELES – (Oct. 8, 2015) – Ronald J. Oudiz, MD, a Los Angeles Biomedical Research Institute (LA BioMed) researcher, will be honored for his many contributions to the pulmonary hypertension field when he receives the 2015 Legacy Award on Oct. 30 from the California Chapter of the Pulmonary Hypertension Association @PHACalifornia
LOS ANGELES – (August 10, 2015) – Nagendra Mishra, PhD, a Los Angeles Biomedical Research Institute (LA BioMed) researcher will be honored by the American Society of Microbiology with a 2015 Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) Young Investigator Award during the conference Sept. 17-21 in San Diego.
LOS ANGELES - (August 6, 2015) - Taking medications as prescribed is challenging for many patients, and following doctors' orders regarding medication often varies over time and among different patients. The consequences of failing to follow the prescribed medication regimen range from mild to life-threatening, depending on the medication and the illness or condition being treated.
Study finds Bathing Patients in Chlorhexidine Reduced MRSA Contamination
LOS ANGELES – (May 15, 2015) – Holding hope for a relatively inexpensive way to improve care and prevent the spread of deadly hospital-acquired infections, a new study presented today reports that bathing patients in a common hospital soap, called chlorhexidine, was equally effective in preventing the transmission of the methicillin-resistant Staphylococcus aureus (MRSA) as the common practice of having healthcare workers avoid physical contact with the patients.
Rise in Infection Rates is Topic for IDAC Presentation May 2 in Costa Mesa
LOS ANGELES – (April 20, 2015) – At the Infectious Disease Association of California (IDAC) symposium in Costa Mesa on May 2, James McKinnell, MD, a Los Angeles Biomedical Research Institute (LA BioMed) infectious disease specialist, is scheduled to discuss how physicians can protect their patients against Carbapenem-resistant Enterobacteriaceae (CRE), a family of bacteria that are difficult to treat because they have high levels of resistance to antibiotics.